¿Emergencia médica?¿Emergencia? Llame al 911. Salas de emergencias más cercanasEmergencias cercanas

Empresa farmacéutica (etiquetadora ante la FDA)

Teva Pharmaceuticals USA, Inc.

Código de etiquetadora NDCs: 0093, 0172, 0480, 0555, 0575, 16252, 50111, 51759, 57844, 63459

¿Qué es una etiquetadora?

La empresa cuyo nombre aparece en el envase y en el directorio de códigos nacionales de medicamentos (NDC) de la FDA. Puede fabricar el medicamento o vender uno fabricado por otra empresa. La primera parte de cada código NDC identifica a la etiquetadora.

Solo datos oficiales de la FDA

Los productos, aprobaciones y retiros vienen de la FDA (directorio NDC, Drugs@FDA, informes de retiros). Los retiros se vinculan a esta empresa por el código NDC del producto retirado.

Si tiene preguntas sobre su medicamento, hable con su médico o farmacéutico. En una emergencia, llame al 911.

De un vistazo

435Productos (NDC)

Medicamentos con receta

Mostrar los otros 115 medicamentos

Solicitudes de la FDA de estos productos

  • NDA: Solicitud de nuevo medicamento (NDA): así se aprueba un medicamento nuevo, normalmente de marca.
  • ANDA: Solicitud abreviada (ANDA): así se aprueba una versión genérica.
  • BLA: Solicitud de licencia de productos biológicos (BLA): así se aprueba un medicamento biológico (hecho a partir de células vivas).
AprobadaSolicitudMedicamentoPatrocinador
19 de julio de 2024BLA761340 Eculizumab-aeeb
EPYSQLI
Samsung Bioepis Co Ltd
16 de abril de 2024BLA761343 Ustekinumab-aekn
SELARSDI
Alvotech USA Inc
16 de noviembre de 2023ANDA208569 Teriparatide (teriparatide acetate)
TERIPARATIDE
Teva Pharms USA
28 de abril de 2023NDA213586 Risperidone
UZEDY
Teva
17 de febrero de 2023ANDA215408 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Teva Pharms
9 de noviembre de 2022ANDA212710 Penciclovir
PENCICLOVIR
Teva Pharms USA
27 de enero de 2022ANDA090977 Lanthanum carbonate
LANTHANUM CARBONATE
Barr
13 de diciembre de 2021ANDA213948 Fluticasone propionate and salmeterol
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Teva Pharms USA
30 de noviembre de 2021ANDA213803 Sunitinib malate
SUNITINIB MALATE
Teva Pharms USA
22 de junio de 2021ANDA091141 Formoterol fumarate
FORMOTEROL FUMARATE
Teva Pharms USA Inc
26 de abril de 2021ANDA214326 Tiopronin
TIOPRONIN
Teva Pharms USA Inc
11 de febrero de 2021ANDA214549 Erythromycin
ERYTHROMYCIN
Teva Pharms USA Inc
13 de enero de 2021ANDA204305 Etonogestrel and ethinyl estradiol
ETHINYL ESTRADIOL; ETONOGESTREL
Teva Pharms USA Inc
15 de julio de 2019ANDA210118 Icatibant
ICATIBANT ACETATE
Teva Pharms USA
9 de mayo de 2019ANDA207873 Mesalamine
MESALAMINE
Teva Pharms USA
20 de marzo de 2019ANDA211455 Methylergonovine maleate
METHYLERGONOVINE MALEATE
Teva Pharms USA
27 de febrero de 2019ANDA211125 Oseltamivir phosphate
OSELTAMIVIR PHOSPHATE
Teva Pharms USA
20 de noviembre de 2018ANDA204937 Buprenorphine
BUPRENORPHINE
Watson Labs Teva
9 de noviembre de 2018ANDA091215 Efavirenz, emtricitabine and tenofovir disoproxil fumarate
EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
Teva Pharms USA
26 de octubre de 2018ANDA211510 Liothyronine sodium
LIOTHYRONINE SODIUM
Teva Pharms USA
14 de septiembre de 2018BLA761089 Fremanezumab-vfrm
AJOVY
Teva Pharms USA
16 de agosto de 2018ANDA090589 Epinephrine
EPINEPHRINE (AUTOINJECTOR)
Teva Pharms USA
21 de septiembre de 2017ANDA208784 Lansoprazole
LANSOPRAZOLE
Teva Pharms USA
21 de julio de 2017ANDA206388 Estradiol
ESTRADIOL
Teva Pharms USA
27 de junio de 2017ANDA202040 Eletriptan hydrobromide
ELETRIPTAN HYDROBROMIDE
Teva Pharms USA
Mostrar las otras 100 solicitudes
AprobadaSolicitudMedicamentoPatrocinador
8 de junio de 2017ANDA090894 Emtricitabine and tenofovir disoproxil fumarate
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Teva Pharms USA
30 de mayo de 2017ANDA079022 Atomoxetine
ATOMOXETINE HYDROCHLORIDE
Teva Pharms USA
27 de marzo de 2017ANDA205300 Atorvastatin
ATORVASTATIN CALCIUM
Teva Pharms USA
27 de enero de 2017NDA208799 Fluticasone propionate and salmeterol
AIRDUO DIGIHALER, AIRDUO RESPICLICK
Teva Pharm
22 de noviembre de 2016ANDA079141 Tolterodine tartrate
TOLTERODINE TARTRATE
Teva Pharms USA
3 de noviembre de 2016ANDA202491 Olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Teva Pharms USA
4 de agosto de 2016ANDA204285 Imatinib mesylate
IMATINIB MESYLATE
Teva Pharms USA
9 de marzo de 2016ANDA077342 Sildenafil
SILDENAFIL CITRATE
Teva
8 de marzo de 2016ANDA204548 Budesonide
BUDESONIDE
Teva Pharms USA
27 de enero de 2016ANDA079011 Fluvastatin
FLUVASTATIN SODIUM
Teva Pharms USA
7 de diciembre de 2015NDA208194 Bendamustine hydrochloride
BENDEKA
Eagle Pharms
25 de noviembre de 2015ANDA090308 Clozapine
CLOZAPINE
Barr Labs Inc
28 de agosto de 2015ANDA091059 Erlotinib
ERLOTINIB HYDROCHLORIDE
Teva Pharms USA Inc
7 de julio de 2015ANDA078027 Almotriptan
ALMOTRIPTAN MALATE
Teva Pharms USA
23 de febrero de 2015ANDA077006 Tolterodine tartrate
TOLTERODINE TARTRATE
Ivax Sub Teva Pharms
22 de abril de 2014ANDA091673 Atazanavir
ATAZANAVIR SULFATE
Teva Pharms USA
4 de marzo de 2014ANDA078193 Raloxifene hydrochloride
RALOXIFENE HYDROCHLORIDE
Teva Pharms USA
10 de enero de 2014ANDA077210 Pioglitazone
PIOGLITAZONE HYDROCHLORIDE
Teva Pharms USA
19 de noviembre de 2013ANDA078908 Dexmethylphenidate hydrochloride
DEXMETHYLPHENIDATE HYDROCHLORIDE
Teva Pharms USA
19 de noviembre de 2013ANDA202731 Dexmethylphenidate hydrochloride
DEXMETHYLPHENIDATE HYDROCHLORIDE
Teva Pharms USA
10 de octubre de 2013ANDA091589 Tobramycin
TOBRAMYCIN
Teva Pharms USA
16 de septiembre de 2013ANDA091649 Capecitabine
CAPECITABINE
Teva Pharms USA
26 de abril de 2013ANDA090297 Levalbuterol
LEVALBUTEROL HYDROCHLORIDE
Teva Pharms USA
4 de abril de 2013ANDA091455 Acitretin
ACITRETIN
Barr Labs Inc
4 de abril de 2013ANDA202897 Acitretin
ACITRETIN
Teva Pharms USA
25 de marzo de 2013ANDA202074 Olanzapine and fluoxetine
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Teva Pharms
31 de diciembre de 2012ANDA077263 Rizatriptan benzoate
RIZATRIPTAN BENZOATE
Teva Pharms
28 de septiembre de 2012ANDA091661 Quinine sulfate
QUININE SULFATE
Teva Pharms
19 de junio de 2012ANDA077528 Olanzapine and fluoxetine
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Teva Pharms
12 de junio de 2012ANDA078407 Fluvastatin
FLUVASTATIN SODIUM
Teva Pharms
17 de mayo de 2012ANDA076999 Clopidogrel
CLOPIDOGREL BISULFATE
Teva
3 de mayo de 2012ANDA091347 Vardenafil
VARDENAFIL HYDROCHLORIDE
Teva Pharms
30 de marzo de 2012ANDA077369 Irbesartan and hydrochlorothiazide
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Teva
27 de marzo de 2012ANDA077745 Quetiapine
QUETIAPINE FUMARATE
Teva Pharms
30 de enero de 2012ANDA077243 Olanzapine
OLANZAPINE
Barr Labs Inc
22 de agosto de 2011ANDA090199 Levocetirizine dihydrochloride
LEVOCETIRIZINE DIHYDROCHLORIDE
Teva Pharms
3 de junio de 2011ANDA090289 Letrozole
LETROZOLE
Teva Pharms
23 de mayo de 2011ANDA091169 Eszopiclone
ESZOPICLONE
Teva
28 de junio de 2010ANDA076565 Venlafaxine
VENLAFAXINE HYDROCHLORIDE
Teva
28 de junio de 2010ANDA078058 Anastrozole
ANASTROZOLE
Teva Pharms
11 de mayo de 2010ANDA079193 Estradiol and norethindrone acetate
ESTRADIOL AND NORETHINDRONE ACETATE
Barr
6 de abril de 2010ANDA077157 Losartan potassium and hydrochlorothiazide
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Teva Pharms
25 de marzo de 2010NDA022483 Imiquimod
ZYCLARA
Bausch
25 de enero de 2010NDA022341 Liraglutide
VICTOZA
Novo Nordisk Inc
10 de noviembre de 2009ANDA077255 Lansoprazole
LANSOPRAZOLE
Teva Pharms
6 de noviembre de 2009ANDA076221 Norethindrone acetate and ethinyl estradiol
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
Barr Labs Inc
6 de mayo de 2009ANDA065491 Mycophenolate mofetil
MYCOPHENOLATE MOFETIL
Teva Pharms
18 de noviembre de 2008ANDA077519 Budesonide
BUDESONIDE
Teva Pharms
31 de octubre de 2008NDA022301 Mesalamine
APRISO
Salix
5 de octubre de 2007ANDA077132 Risedronate
RISEDRONATE SODIUM
Teva Pharms USA
5 de septiembre de 2007ANDA076373 Carvedilol
CARVEDILOL
Teva
24 de agosto de 2007ANDA077487 Famciclovir
FAMCICLOVIR
Teva Pharms
15 de junio de 2007NDA021875 Armodafinil
NUVIGIL
Nuvo Pharms
9 de mayo de 2007ANDA065368 Cefdinir
CEFDINIR
Teva Pharms
4 de mayo de 2007ANDA065332 Cefdinir
CEFDINIR
Teva Pharms
7 de marzo de 2007ANDA077750 Cabergoline
CABERGOLINE
Ivax Sub Teva Pharms
1 de febrero de 2007NDA021777 Cyclobenzaprine hydrochloride
AMRIX
Teva Pharms Intl
31 de enero de 2007NDA021234 Diclofenac epolamine
FLECTOR
Ibsa
3 de agosto de 2006ANDA076690 Venlafaxine
VENLAFAXINE HYDROCHLORIDE
Teva
6 de julio de 2006ANDA065246 Azithromycin
AZITHROMYCIN
Pliva
5 de julio de 2006ANDA040616 Warfarin sodium
WARFARIN SODIUM
Pliva
16 de mayo de 2006NDA021641 Rasagiline
AZILECT
Teva
24 de abril de 2006ANDA076056 Pravastatin sodium
PRAVASTATIN SODIUM
Aurobindo Pharma USA
20 de enero de 2006ANDA065282 Cefadroxil
CEFADROXIL
Teva Pharms
5 de enero de 2006ANDA077317 Isradipine
ISRADIPINE
Watson Labs Teva
6 de diciembre de 2005ANDA065208 Cefprozil
CEFPROZIL
Teva
14 de noviembre de 2005ANDA065218 Azithromycin
AZITHROMYCIN
Pliva
14 de noviembre de 2005ANDA065223 Azithromycin
AZITHROMYCIN
Pliva
14 de noviembre de 2005ANDA065225 Azithromycin
AZITHROMYCIN
Pliva
28 de octubre de 2005ANDA077270 Glipizide and metformin hydrochloride
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Teva Pharms
10 de agosto de 2005ANDA077194 Clonazepam
CLONAZEPAM
Barr
29 de marzo de 2005ANDA065110 Cyclosporine
CYCLOSPORINE
Ivax Sub Teva Pharms
25 de marzo de 2005ANDA065078 Cyclosporine
CYCLOSPORINE
Ivax Sub Teva Pharms
24 de noviembre de 2004ANDA077027 Cilostazol
CILOSTAZOL
Teva
29 de octubre de 2004NDA021457 Albuterol sulfate
PROAIR HFA
Teva Branded Pharm
9 de junio de 2004ANDA076794 Ciprofloxacin
CIPROFLOXACIN HYDROCHLORIDE
Watson Labs
25 de mayo de 2004ANDA065089 Amoxicillin and clavulanate potassium (amoxicillin / clavulanate)
AMOXICILLIN AND CLAVULANATE POTASSIUM
Chartwell Rx
12 de marzo de 2004ANDA065162 Amoxicillin and clavulanate potassium (amoxicillin / clavulanate)
AMOXICILLIN AND CLAVULANATE POTASSIUM
Chartwell Rx
29 de diciembre de 2003ANDA076392 Mefloquine hydrochloride
MEFLOQUINE HYDROCHLORIDE
Barr
7 de noviembre de 2003ANDA065085 Mupirocin
MUPIROCIN
Teva
16 de septiembre de 2003ANDA076037 Nefazodone hydrochloride
NEFAZODONE HYDROCHLORIDE
Teva
30 de mayo de 2003ANDA076346 Torsemide
TORSEMIDE
Pliva Pharm Ind
30 de mayo de 2003ANDA076380 Norethindrone acetate and ethinyl estradiol
JUNEL 1/20
Barr Labs
30 de mayo de 2003ANDA076381 Norethindrone acetate and ethinyl estradiol
JUNEL 1.5/30
Barr
8 de mayo de 2003ANDA076204 Moexipril hydrochloride
MOEXIPRIL HYDROCHLORIDE
Teva
11 de abril de 2003ANDA076135 Isotretinoin
CLARAVIS
Teva Pharms USA
11 de abril de 2003ANDA076356 Isotretinoin
CLARAVIS
Teva Pharms USA
30 de diciembre de 2002NDA021478 Acyclovir
ZOVIRAX
Bausch
4 de diciembre de 2002ANDA065119 Amoxicillin
AMOXICILLIN
Chartwell Rx
30 de octubre de 2002ANDA065101 Amoxicillin and clavulanate potassium (amoxicillin / clavulanate)
AMOXICILLIN AND CLAVULANATE POTASSIUM
Chartwell Rx
29 de octubre de 2002ANDA065096 Amoxicillin and clavulanate potassium (amoxicillin / clavulanate)
AMOXICILLIN AND CLAVULANATE POTASSIUM
Chartwell Rx
4 de septiembre de 2002ANDA065058 Cefaclor
CEFACLOR
Teva
19 de junio de 2002ANDA075977 Tramadol hydrochloride
TRAMADOL HYDROCHLORIDE
Teva
28 de febrero de 2002ANDA075022 Buspirone
BUSPIRONE HYDROCHLORIDE
Teva
11 de febrero de 2002ANDA040422 Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Barr
29 de enero de 2002ANDA075452 Fluoxetine
FLUOXETINE HYDROCHLORIDE
Teva
29 de enero de 2002ANDA076001 Fluoxetine
FLUOXETINE HYDROCHLORIDE
Teva Pharms USA
17 de diciembre de 2001ANDA075551 Lovastatin
LOVASTATIN
Teva
12 de octubre de 2001ANDA075765 Calcitriol
CALCITRIOL
Teva
25 de mayo de 2001ANDA075951 Norethindrone acetate
NORETHINDRONE ACETATE
Barr

Se muestran las 125 más recientes de 217 solicitudes. Listas completas: Drugs@FDA →

El patrocinador es la empresa titular de la solicitud ante la FDA; puede ser distinta de la etiquetadora.

Cronología de retiros

2026

  1. 29 de septiembre de 2026 · Clase II · En curso · D-0038-2027 · Metoclopramide

    Presence of Foreign Tablets/Capsules

    Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05

  2. 24 de agosto de 2026 · Clase II · En curso · D-0834-2026 · Trazodone hydrochloride

    Presence of Foreign Tablets/Capsules

    traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01

  3. 6 de abril de 2026 · Clase II · En curso · D-0521-2026 · Isotretinoin

    Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

    Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx

2025

  1. 7 de octubre de 2025 · Clase II · En curso · D-0104-2026 · Prazosin hydrochloride

    CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

    Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4067-01, b) 1000 Capsules, NDC 0093-4067-10

  2. 7 de octubre de 2025 · Clase II · En curso · D-0106-2026 · Prazosin hydrochloride

    CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

    Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4069-01, b) 250 Capsules, NDC 0093-4069-52, c) 500 Capsules, NDC 0093-

  3. 7 de octubre de 2025 · Clase II · En curso · D-0105-2026 · Prazosin hydrochloride

    CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

    Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4068-01, b) 1000 Capsules, NDC 0093-4068-10

  4. 11 de junio de 2025 · Clase III · En curso · D-0527-2025 · Pitavastatin

    Failed Impurities/Degradation Specifications.

    Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiw

  5. 11 de junio de 2025 · Clase III · En curso · D-0526-2025 · Pitavastatin

    Failed Impurities/Degradation Specifications.

    Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiw

  6. 23 de mayo de 2025 · Clase II · En curso · D-0473-2025 · Metoclopramide

    Presence of foreign tablets/capsules.

    Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

2024

  1. 25 de enero de 2024 · Clase III · En curso · D-0321-2024 · Norethindrone and ethinyl estradiol

    Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

    Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454,

Mostrar los 49 retiros anteriores

2023

  1. 5 de julio de 2023 · Clase II · Cerrado por la FDA · D-0913-2023 · Sunitinib malate

    Failed Moisture Limits: Water (moisture) content above the approved product specifications.

    Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28

2022

  1. 29 de agosto de 2022 · Clase II · Cerrado por la FDA · D-1539-2022 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

    Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, Rx Only, 100 tablets per bottle, Teva Pharmaceut

  2. 23 de agosto de 2022 · Clase II · Cerrado por la FDA · D-1473-2022 · Neomycin sulfate

    CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

    Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

  3. 13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1075-2022 · Mupirocin

    cGMP deviations: Temperature abuse

    Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA

  4. 26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0180-2024 · Estradiol

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 0555-0899-02

  5. 26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0165-2024 · Amoxicillin

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.

  6. 26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0201-2024 · Warfarin sodium

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01

  7. 26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0200-2024 · Warfarin sodium

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01

  8. 7 de enero de 2022 · Clase III · Cerrado por la FDA · D-0522-2022 · Estradiol and norethindrone acetate

    Mislabeling

    Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc

  9. 7 de enero de 2022 · Clase III · Cerrado por la FDA · D-0521-2022 · Estradiol and norethindrone acetate

    Mislabeling

    Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA In

2021

  1. 15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0577-2021 · Epinephrine

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    EPINEPHRINE INJECTION USP, 0.3MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS) 2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5986-27

  2. 15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0574-2021 · Neomycin sulfate

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC: 0093-1177-01

  3. 15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0578-2021 · Epinephrine

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    EPINEPHRINE INJECTION USP, 0.15 MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS) 2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5985-27

  4. 15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0575-2021 · Bisoprolol fumarate and hydrochlorothiazide

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count bottles, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-3241-01 RX; TABLETS

  5. 15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0576-2021 · Penicillin v potassium

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    PENICILLIN V POT for Oral Solution, USP 125mg/5mL 100mL (when mixed) Rx Only, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4125-73

2020

  1. 4 de septiembre de 2020 · Clase II · Cerrado por la FDA · D-0003-2021 · Buprenorphine

    Failed Stability Specifications: Below specification result for buprenorphine release rate.

    Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva

  2. 24 de agosto de 2020 · Clase II · Cerrado por la FDA · D-1566-2020 · Cephalexin

    Sub-Potent Drug: Out of specification test results for potency (below specification).

    Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.

  3. 24 de agosto de 2020 · Clase II · Cerrado por la FDA · D-0012-2021 · Cephalexin

    CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

    Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA,

  4. 24 de agosto de 2020 · Clase II · Cerrado por la FDA · D-0013-2021 · Cephalexin

    CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

    Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4177-73, b) 200 mL bottle when mixed, NDC 0093-4177-74, Teva Pharmaceuticals USA,

  5. 22 de mayo de 2020 · Clase II · Cerrado por la FDA · D-1285-2020 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Some bottles may contain mixed strengths of the product.

    Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wa

  6. 22 de mayo de 2020 · Clase II · Cerrado por la FDA · D-1287-2020 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Some bottles may contain mixed strengths of the product.

    Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 20 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North W

  7. 22 de mayo de 2020 · Clase II · Cerrado por la FDA · D-1286-2020 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Some bottles may contain mixed strengths of the product.

    Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North W

  8. 5 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1260-2020 · Epinephrine

    CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.

    Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27

2019

  1. 11 de marzo de 2019 · Clase III · Cerrado por la FDA · D-1006-2019 · Lansoprazole

    Subpotent Drug.

    Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufact

2018

  1. 21 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-0001-2019 · Clozapine

    Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.

    Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed wit

  2. 19 de marzo de 2018 · Clase II · Cerrado por la FDA · D-0620-2018 · Estradiol

    Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

    Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wale

2017

  1. 28 de noviembre de 2017 · Clase III · Cerrado por la FDA · D-0108-2018 · Penicillin v potassium

    Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.

    Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only, Manufactured In Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuti

  2. 24 de julio de 2017 · Clase II · Cerrado por la FDA · D-1056-2017 · Famotidine

    Failed Tablet/Capsule Specification; out of specification for tablet weight

    Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60

2016

  1. 24 de junio de 2016 · Clase II · Cerrado por la FDA · D-1470-2016 · Amoxicillin

    Superpotent drug: Out of specification test result for assay during stability testing.

    Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76

2015

  1. 21 de diciembre de 2015 · Clase II · Cerrado por la FDA · D-0732-2016 · Capecitabine

    Failed Dissolution Specifications: low test results at the 18 month time-point

    Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, P

  2. 12 de noviembre de 2015 · Clase II · Cerrado por la FDA · D-0566-2016 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

    DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals

  3. 20 de octubre de 2015 · Clase III · Cerrado por la FDA · D-0521-2016 · Irbesartan and hydrochlorothiazide

    Labeling: Incorrect or Missing Lot AND/OR Exp Date.

    Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL IND

  4. 24 de junio de 2015 · Clase II · Cerrado por la FDA · D-1283-2015 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Failed Impurities/Degradation Specifications: out of specification for unknown impurity

    Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, (CII), 10 mg (Mixed Salts of a Single Entity Amphetamine Product), 100 count bottles, manufactured at Barr L

  5. 13 de abril de 2015 · Clase II · Cerrado por la FDA · D-0971-2015 · Fluoxetine

    Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

    Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manu

  6. 13 de abril de 2015 · Clase II · Cerrado por la FDA · D-0970-2015 · Fluoxetine

    Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

    Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01

2014

  1. 8 de octubre de 2014 · Clase II · Cerrado por la FDA · D-0050-2015 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    Failed Impurities/Degradation Specifications: Out of specification for unknown impurities.

    DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets, (CII), 10 mg, 100 Tablet Bottles, Rx Only. Teva Pharmaceuticals USA , Sellersville, PA 18960, NDC: 0555-0972

  2. 29 de mayo de 2014 · Clase II · Cerrado por la FDA · D-1430-2014 · Fluvastatin

    Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.

    Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by Teva Pharmaceutical IND LTD, Jerusalem, Israel, NDC 0093-7442-56

  3. 1 de mayo de 2014 · Clase II · Cerrado por la FDA · D-1408-2014 · Dextroamphetamine

    Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.

    Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.

  4. 12 de febrero de 2014 · Clase II · Cerrado por la FDA · D-1280-2014 · Fluoxetine

    Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

    Fluoxetine Capsules USP, 20 mg, packaged in a) 100-count bottles (NDC 50111-648-01), b) 500-count bottles (NDC 50111-648-02), c) 1000-count bottles (NDC 50111-648-03), and d) 2000-count bottles (NDC 50111-648-44), Rx onl

  5. 12 de febrero de 2014 · Clase II · Cerrado por la FDA · D-1281-2014 · Fluoxetine

    Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

    Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 501

  6. 24 de enero de 2014 · Clase II · Cerrado por la FDA · D-1093-2014 · Hydroxyzine

    CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.

    Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sellersville, PA. NDC 0555-0324-02

  7. 24 de enero de 2014 · Clase II · Cerrado por la FDA · D-1095-2014 · Hydroxyzine

    CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.

    Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.

  8. 24 de enero de 2014 · Clase II · Cerrado por la FDA · D-1094-2014 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

    CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were manufactured using unapproved material: the finished product was not properly quarantined as rejected due to inadequate cleaning of equipment.

    Teva Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg (mixed salts) , 100 count-bottle, Rx Only, Distributed by Teva Pharmaceuticals, USA, Sellersv

2013

  1. 18 de junio de 2013 · Clase III · Cerrado por la FDA · D-803-2013 · Amoxicillin

    Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.

    Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for:

  2. 26 de abril de 2013 · Clase III · Cerrado por la FDA · D-598-2013 · Amoxicillin

    Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner foil seal of the bottles.

    Amoxicillin for Oral Suspension, USP 400mg/5mL, NDC 0093-4161-78 (75ml) and 0093-4161-73 (100mL)

  3. 15 de marzo de 2013 · Clase III · Cerrado por la FDA · D-682-2013 · Norethindrone acetate and ethinyl estradiol

    Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

    Junel(TM) Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), 28 day regimen, Rx only, Barr laboratories, Pomona, NY --- NDC 0555-9028-58

  4. 26 de febrero de 2013 · Clase II · Cerrado por la FDA · D-247-2013 · Cefdinir

    Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

    Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.

2012

  1. 24 de abril de 2012 · Clase III · Cerrado por la FDA · D-128-2013 · Cabergoline

    Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

    CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

  2. 2 de abril de 2012 · Clase II · Cerrado por la FDA · D-1396-2012 · Mefloquine hydrochloride

    Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.

    Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Cart

¿Qué significan las clases de retiro?

Clase I: El tipo más grave: existe una probabilidad razonable de que usar el producto cause problemas de salud graves o la muerte.
Clase II: Usar el producto puede causar problemas de salud temporales o reversibles con tratamiento, o la probabilidad de problemas graves es remota.
Clase III: No es probable que usar el producto cause problemas de salud (por ejemplo, un problema de etiquetado o de envase).

Fuentes

  1. NDC Directory (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
  2. Drugs@FDA (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
  3. Drug recall enforcement reports (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 10 de noviembre de 2026, consultados el 14 de noviembre de 2026

Buscador de informes de retiros de la FDA → · Informar un error →